These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4791935)

  • 21. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary dapsone-resistant leprosy in Shanghai Municipality.
    Ji BH; Chen JK; Zhang JL; Hou YH; Ni GX; Zhang RB
    Lepr Rev; 1983 Sep; 54(3):197-202. PubMed ID: 6355724
    [No Abstract]   [Full Text] [Related]  

  • 23. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter: Low doses of dapsone in the treatment of leprosy.
    Jopling WH
    Int J Lepr Other Mycobact Dis; 1972; 40(4):419. PubMed ID: 4677498
    [No Abstract]   [Full Text] [Related]  

  • 26. Dapsone resistance in patients attending Central Leprosy Teaching and Research Institute, Chengalpattu (South India).
    Bhatia VN; Balakrishnan S; Seshadri PS; Neelan PN; Roy RG
    Indian J Lepr; 1984; 56(3):587-94. PubMed ID: 6396340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Advances in the chemotherapy of leprosy].
    Grosset J
    Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 29. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

  • 30. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dapsone induced psychosis.
    Balkrishna ; Bhatia MS
    J Indian Med Assoc; 1989 May; 87(5):120-1. PubMed ID: 2600436
    [No Abstract]   [Full Text] [Related]  

  • 32. Secondary sulphone resistance in leprosy (Report of a case).
    Lal S; Jaganath C; Garg BR; Paneerselvam R
    Lepr India; 1980 Apr; 52(2):299-301. PubMed ID: 7005542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary dapsone resistance in leprotic patients of the Shanghai district].
    Ji BH
    Zhonghua Yi Xue Za Zhi; 1983 Apr; 63(4):244-7. PubMed ID: 6413025
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical recognition and therapeutic confirmation of sulphone resistant leprosy patients.
    Choudhury SB
    Lepr India; 1976 Oct; 48(4 Suppl):784-6. PubMed ID: 1026817
    [No Abstract]   [Full Text] [Related]  

  • 35. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment.
    Shepard CC; Levy L; Fasal P
    Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of leprosy in Papua New Guinea.
    Reé GH
    P N G Med J; 1982 Sep; 25(3):142. PubMed ID: 6961638
    [No Abstract]   [Full Text] [Related]  

  • 37. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent advances in the study of the leprosy bacillus.
    Rees RJ
    Sci Basis Med Annu Rev; 1969; ():320-35. PubMed ID: 4917843
    [No Abstract]   [Full Text] [Related]  

  • 39. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relaspe in leprosy.
    Br Med J; 1977 Oct; 2(6092):914-5. PubMed ID: 912367
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.